Literature DB >> 25638651

Association of polyfluoroalkyl chemical exposure with serum lipids in children.

Xiao-Wen Zeng1, Zhengmin Qian2, Brett Emo3, Michael Vaughn4, Jia Bao5, Xiao-Di Qin1, Yu Zhu1, Jie Li1, Yungling Leo Lee6, Guang-Hui Dong7.   

Abstract

Perfluoroalkyl and polyfluoroalkyl substances (PFASs), as well as polymers of PFASs, have been widely used in commercial applications and have been detected in humans and the environment. Previous epidemiological studies have shown associations between particular PFAS chemicals and serum lipid concentrations in adults, particularly perfluorooctane sulfonic acid (PFOS) and perfluorooctanoic acid (PFOA). There exists, however, limited information concerning the effect of PFASs have on serum lipids among children. In the present cross-sectional study, 225 Taiwanese children (12-15 years of age) were recruited to determine the relationship between serum level PFASs and lipid concentration. Results showed that eight out of ten particular PFASs were detected in the serum of >94% of the participants. Serum PFOS and perfluorotetradecanoic acid (PFTA) levels were at an order of magnitude higher than the other PFASs, with arithmetical means of 32.4 and 30.7 ng/ml in boys and 34.2 and 27.4 ng/ml in girls, respectively. However, the variation in serum PFTA concentration was quite large. Following covariate adjustment, linear regression models revealed that PFOS, PFOA, and perfluorononanoic acid (PFNA) were positively associated with total cholesterol (TC), low-density lipoprotein (LDL) and triglycerides (TG), particularly for PFOS and PFTA. Quartile analysis, with the lowest exposure quartile as a reference, yielded associations between serum PFTA and elevations in TC (p=0.002) and LDL (p=0.004). Though not statistically significant, high-density lipoprotein (HDL) appeared to decrease linearly across quartiles for PFOS and PFOA exposure. In conclusion, a significant association was observed between serum PFASs and lipid level in Taiwanese children. These findings for PFTA are novel, and emphasize the need to investigate the exposure route and toxicological evidence of PFASs beyond PFOS and PFOA.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Children; Polyfluoroalkyl compounds; Polyfluoroalkyl substances; Serum lipids

Mesh:

Substances:

Year:  2015        PMID: 25638651     DOI: 10.1016/j.scitotenv.2015.01.042

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  19 in total

1.  Per- and polyfluoroalkyl substances and blood lipid levels in pre-diabetic adults-longitudinal analysis of the diabetes prevention program outcomes study.

Authors:  Pi-I D Lin; Andres Cardenas; Russ Hauser; Diane R Gold; Ken P Kleinman; Marie-France Hivert; Abby F Fleisch; Antonia M Calafat; Thomas F Webster; Edward S Horton; Emily Oken
Journal:  Environ Int       Date:  2019-05-28       Impact factor: 9.621

2.  Complex relationships between perfluorooctanoate, body mass index, insulin resistance and serum lipids in young girls.

Authors:  Cecily S Fassler; Sara E Pinney; Changchun Xie; Frank M Biro; Susan M Pinney
Journal:  Environ Res       Date:  2019-06-26       Impact factor: 6.498

3.  Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.

Authors:  Ana M Mora; Abby F Fleisch; Sheryl L Rifas-Shiman; Jennifer A Woo Baidal; Larissa Pardo; Thomas F Webster; Antonia M Calafat; Xiaoyun Ye; Emily Oken; Sharon K Sagiv
Journal:  Environ Int       Date:  2017-11-20       Impact factor: 9.621

4.  Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group.

Authors:  Tony T Koshy; Teresa M Attina; Akhgar Ghassabian; Joseph Gilbert; Lauren K Burdine; Michael Marmor; Masato Honda; Dinh Binh Chu; Xiaoxia Han; Yongzhao Shao; Kurunthachalam Kannan; Elaine M Urbina; Leonardo Trasande
Journal:  Environ Int       Date:  2017-09-08       Impact factor: 9.621

5.  Hepatic carboxylesterases are differentially regulated in PPARα-null mice treated with perfluorooctanoic acid.

Authors:  Xia Wen; Angela A Baker; Curtis D Klaassen; J Christopher Corton; Jason R Richardson; Lauren M Aleksunes
Journal:  Toxicology       Date:  2019-01-24       Impact factor: 4.221

6.  The Association Between Perfluoroalkyl Substances and Lipids in Cord Blood.

Authors:  Miranda J Spratlen; Frederica P Perera; Sally Ann Lederman; Morgan Robinson; Kurunthachalam Kannan; Julie Herbstman; Leonardo Trasande
Journal:  J Clin Endocrinol Metab       Date:  2020-01-01       Impact factor: 5.958

7.  The Nrf2a pathway impacts zebrafish offspring development with maternal preconception exposure to perfluorobutanesulfonic acid.

Authors:  Kate M Annunziato; Marjorie Marin; Wenle Liang; Sarah M Conlin; Weipeng Qi; Jeffery Doherty; Jonghwa Lee; John M Clark; Yeonhwa Park; Alicia R Timme-Laragy
Journal:  Chemosphere       Date:  2021-09-02       Impact factor: 7.086

8.  Early-life associations between per- and polyfluoroalkyl substances and serum lipids in a longitudinal birth cohort.

Authors:  Annelise J Blomberg; Yu-Hsuan Shih; Carmen Messerlian; Louise Helskov Jørgensen; Pál Weihe; Philippe Grandjean
Journal:  Environ Res       Date:  2021-05-31       Impact factor: 8.431

9.  Human exposure pathways to poly- and perfluoroalkyl substances (PFAS) from indoor media: A systematic review protocol.

Authors:  Nicole M DeLuca; Michelle Angrish; Amina Wilkins; Kris Thayer; Elaine A Cohen Hubal
Journal:  Environ Int       Date:  2020-12-11       Impact factor: 9.621

10.  Perfluorooctanoic acid induces liver and serum dyslipidemia in humanized PPARα mice fed an American diet.

Authors:  J J Schlezinger; T Hyötyläinen; T Sinioja; C Boston; H Puckett; J Oliver; W Heiger-Bernays; T F Webster
Journal:  Toxicol Appl Pharmacol       Date:  2021-07-10       Impact factor: 4.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.